ACM
MIST icon

ADAR1 Capital Management’s Milestone Pharmaceuticals MIST Stock Holding History

ADAR1 Capital Management’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$134K Hold
100,000
– – 0.01% 256
2026
Q1 		$119K Sell
100,000
-100
-0.1% -$175 0.01% 282
2025
Q4 		$202K Buy
+100,100
New +$216K 0.01% 229
2024
Q4 		– Sell
-27,931
Closed -$42.5K – 269
2024
Q3 		$42.5K Sell
27,931
-174,529
-86% -$254K 0.01% 223
2024
Q2 		$267K Hold
202,460
– – 0.05% 129
2024
Q1 		$362K Buy
+202,460
New +$329K 0.08% 93

Other funds holding MIST

PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

ADAR1 Capital Management's MIST Position: Q2 2026 in Review

ADAR1 Capital Management held its Milestone Pharmaceuticals (MIST) position steady in Q2 2026 at 100,000 shares worth $134K. The position accounts for 0.01% of the portfolio, ranked #256.

ADAR1 Capital Management first reported a position in MIST in Q1 2024 and has held it in 6 quarters since. The position peaked at $362K in Q1 2024. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • ADAR1 Capital Management held 100,000 shares of Milestone Pharmaceuticals worth $134K as of Q2 2026.
  • ADAR1 Capital Management left its Milestone Pharmaceuticals share count unchanged in Q2 2026.
  • Milestone Pharmaceuticals made up 0.01% of ADAR1 Capital Management's portfolio in Q2 2026, its #256 holding.
  • ADAR1 Capital Management first reported a position in Milestone Pharmaceuticals in Q1 2024 and has held it in 6 quarters since.
  • ADAR1 Capital Management's Milestone Pharmaceuticals position peaked at $362K in Q1 2024.
  • 78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.